MedPath

ENDO PHARMACEUTICALS INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:6
Completed:0

Trial Phases

2 Phases

Phase 1:1
Phase 3:3

Drug Approvals

9

FDA:9

Drug Approvals

LIDODERM

Approval Date
Nov 27, 2022
FDA

XIAFLEX

Approval Date
Jul 31, 2022
FDA

PERCOCET

Approval Date
Jul 12, 2022
FDA

Edex

Approval Date
Jul 11, 2022
FDA

SUPPRELIN

Approval Date
Apr 27, 2022
FDA

FORTESTA

Approval Date
Jan 31, 2022
FDA

Testim

Approval Date
Aug 25, 2021
FDA

Aveed

Approval Date
Aug 24, 2021
FDA

Testopel

Approval Date
Aug 24, 2018
FDA

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (75.0%)
Phase 1
1 (25.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.